Herrstedt, J, Rolski, J, Guckert, M, Camlett, I, Russo, M W, Strausz, J & Aziz, Z 2008, ' Phase III results for the Novel Neurokinin-1 (NK-1) Receptor Antagonist, Casopitant: Single Oral Dosing Regimen for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients (Pts) Receiving Multiple Cycles of Highly Emetogenic Chemotherapy (HEC) ', American Society of Clinical Oncology, Chicago, United States, 30/05/2008-03/06/2008 .